Lilly Defeats Cymbalta Label Suit As Possible MDL Looms
By Michael Lipkin ( November 7, 2014, 8:40 PM EST) -- A New York federal judge on Friday ruled Eli Lilly & Co.'s label for antidepressant drug Cymbalta adequately warned doctors about possible withdrawal symptoms and tossed a suit claiming the label was inaccurate, potentially hurting the plaintiffs' chances to consolidate more than two dozen similar cases in multidistrict litigation....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.